Prostate Cancer - Results from #40

Different predictive values of microvessel density for biochemical recurrence among different PCa populations: A systematic review and meta-analysis. August 10, 2022

Avenda Health Receives FDA Investigational Device Exemption for AI-enabled Prostate Cancer Therapy August 9, 2022

Predictors and trends of opioid-sparing radical prostatectomy from a large national cohort. August 9, 2022

Satisfaction with Clinician-Led Germline Genetic Counseling in Patients with Prostate Cancer. August 9, 2022

The role of multiparametric ultrasound in the detection of clinically significant prostate cancer. August 9, 2022

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies. August 9, 2022

A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer. August 9, 2022

The Low Rate of Adherence to Checklist for Artificial Intelligence in Medical Imaging Criteria Among Published Prostate MRI Artificial Intelligence Algorithms. August 8, 2022

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? August 8, 2022

Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans. August 8, 2022

Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. August 8, 2022

Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy. August 8, 2022

FDA Approves Darolutamide Tablets for Metastatic Hormone-Sensitive Prostate Cancer August 5, 2022

Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression August 5, 2022

Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network. August 5, 2022

Five-Year Prospective Observational Study of African-American Men on Active Surveillance for Prostate Cancer Demonstrates Race Is Not Predictive of Oncologic Outcomes. August 5, 2022

How Prostate Cancer Patients are Surveyed may Influence Self-Reported Sexual Function Responses. August 5, 2022

Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison. August 5, 2022

Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up. August 5, 2022

The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells. August 4, 2022

Page 3 of 1242

email news signup